Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist - Wikidata - awgldk - TriplyDB

Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist

Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist

http://www.wikidata.org/entity/Q28288221

about

Attention-modulating effects of cognitive enhancers Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models The histamine H3 receptor: an attractive target for the treatment of cognitive disorders Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist Drug Design for CNS Diseases: Polypharmacological Profiling of Compounds Using Cheminformatic, 3D-QSAR and Virtual Screening Methodologies International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors Two polymorphic forms of human histamine methyltransferase: structural, thermal, and kinetic comparisons Distinct pharmacology of rat and human histamine H(3) receptors: role of two amino acids in the third transmembrane domain Identification and characterization of ZEL-H16 as a novel agonist of the histamine H3 receptor The H3 antagonist, ciproxifan, alleviates the memory impairment but enhances the motor effects of MK-801 (dizocilpine) in rats Drugs for sleep disorders: mechanisms and therapeutic prospects CNTRICS final animal model task selection: control of attention The histaminergic system is involved in psychological stress-induced hyperthermia in rats.Structural basis for inhibition of histamine N-methyltransferase by diverse drugs Histamine in the regulation of wakefulness.Ciproxifan, an H3 receptor antagonist, alleviates hyperactivity and cognitive deficits in the APP Tg2576 mouse model of Alzheimer's disease Protean agonism at histamine H3 receptors in vitro and in vivo Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice.The histamine H3 receptor: from discovery to clinical trials with pitolisant Pharmacological enhancement of memory and executive functioning in laboratory animals.Differential effects of acute and repeat dosing with the H3 antagonist GSK189254 on the sleep-wake cycle and narcoleptic episodes in Ox-/- mice.In vivo demonstration of H3-histaminergic inhibition of cardiac sympathetic stimulation by R-alpha-methyl-histamine and its prodrug BP 2.94 in the dog Alzheimer's disease and age-related memory decline (preclinical)Sleep disturbances, psychiatric disorders, and psychotropic drugs Radiosynthesis and evaluation of an (18)F-labeled positron emission tomography (PET) radioligand for brain histamine subtype-3 receptors based on a nonimidazole 2-aminoethylbenzofuran chemotype.Interaction of nicotinic and histamine H(3) systems in the radial-arm maze repeated acquisition task.Enhanced histaminergic neurotransmission and sleep-wake alterations, a study in histamine H3-receptor knock-out mice.Non-imidazole-based histamine H3 receptor antagonists with anticonvulsant activity in different seizure models in male adult rats.Effects of the H(3) antagonist, thioperamide, on behavioral alterations induced by systemic MK-801 administration in rats.Ciproxifan, a histamine H3 receptor antagonist, reversibly inhibits monoamine oxidase A and B.Histamine H3-receptor-mediated [35S]GTP gamma[S] binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptors.The Effect of Subchronic Dosing of Ciproxifan and Clobenpropit on Dopamine and Histamine Levels in Rats.Ligands for histamine H(3) receptors modulate cell proliferation and migration in rat oxyntic mucosa.Histamine H(3)-receptor antagonists inhibit gastroprotection by (R)-alpha-methylhistamine in the rat.4-Hydroxypiperidines and Their Flexible 3-(Amino)propyloxy Analogues as Non-Imidazole Histamine H₃ Receptor Antagonist: Further Structure⁻Activity Relationship Exploration and In Vitro and In Vivo Pharmacological Evaluation.Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder.

P2860

Q24614793-588BD990-48E5-42CE-A253-8502136BFDE0 Q24650737-357CE75E-753B-4455-B476-DEBD01F28E06 Q24654788-7A7F9734-5E5B-4006-ACE9-1F3CA390E01E Q24671207-E490BC1D-9A01-48F3-8D6D-702A1C424E29 Q26745421-5A6EF169-9C33-4CB7-A247-E6623B8FEF12 Q26827568-2E3A8F14-3626-49F5-AAAE-53A90A824378 Q27634937-8E30B19E-A92F-4042-92DE-265CDFFB28AE Q28344970-F0C97A5A-02D2-491B-A93F-198F333F998E Q28481970-78694B69-6495-4238-A9DB-15754ACB5AF9 Q30473345-7E0352A3-3C04-4FA4-A730-FD7E637E4481 Q30498393-81EBFC34-BC7A-4FED-B71E-6D289332115E Q30527964-BA9542EE-EE35-4FAC-9C73-4B404848B8F8 Q33612330-FA4CA656-7FAA-47FA-BC0C-286C169678F2 Q33613450-7007134F-1B55-4D26-A9A6-09C2EDB99BCB Q34138704-8B523220-980F-4DAB-840E-1D64E8BCBDA7 Q34149546-2EEE3DF7-BD7D-4F47-96EF-B5CAA872D38C Q34228615-227DD5FD-FA15-43F1-A41C-421FD1B9E85C Q34574933-D9D830B7-0967-47C8-9B28-33A4373512B7 Q34629532-A9B56858-D1D1-4AEE-BCF9-FE042E5EAB0B Q34661221-55828B11-73AC-4C68-AECE-9E4E110B0DF5 Q34979043-5E9E9608-D683-491A-B4C4-0234744D28A5 Q35028314-AA2148DE-E5C4-4903-BF27-8113515D8FAF Q35041190-BA9DCA7B-6EA1-40B7-A467-D6720BEC5162 Q35236639-AC1E2C80-F2EE-4EF6-B934-5DC7E15C0AF9 Q35829934-CB423F6E-B47E-495A-8F6E-A40DCC6F5922 Q36015229-289733BA-9DC4-4D15-9F63-EEBF817BD32A Q36775241-5A3C03B6-20BD-40F4-BCE0-7E907240CC62 Q37468677-5CF113CA-AB48-4AEE-996D-6D8E2D1423EF Q37469316-062F5C57-782B-47CC-8BEE-B6414343FD0C Q37584491-B67795A4-7F3F-46E8-9E45-0517DA93E1BE Q42164100-D02AC0C4-FDFB-4C06-BDBC-4C0227ACDD6F Q43011663-9642383A-54FA-45CF-839C-923685CB6790 Q43263690-F90F2FE0-483B-44DE-8350-9C0141A7DD29 Q43263745-EBEDB7A3-FA0C-49CC-A428-9D41EED466D7 Q55108260-50281F10-DB10-4019-99EA-11EDF9ECED60 Q55180784-309CFAD7-8556-4743-80B0-222F8F18E6CA

P2860

Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist

http://www.wikidata.org/entity/Q28288221

description

1998 nî lūn-bûn

@nan

1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Neurochemical and behavioral e ...... stamine H3-receptor antagonist

@ast

Neurochemical and behavioral e ...... stamine H3-receptor antagonist

@en

Neurochemical and behavioral e ...... stamine H3-receptor antagonist

@nl

type

label

Neurochemical and behavioral e ...... stamine H3-receptor antagonist

@ast

Neurochemical and behavioral e ...... stamine H3-receptor antagonist

@en

Neurochemical and behavioral e ...... stamine H3-receptor antagonist

@nl

prefLabel

Neurochemical and behavioral e ...... stamine H3-receptor antagonist

@ast

Neurochemical and behavioral e ...... stamine H3-receptor antagonist

@en

Neurochemical and behavioral e ...... stamine H3-receptor antagonist

@nl

P1433

Q28288221-9D204E1D-8802-43C0-9F3D-66FADE63E337

P1476

Q28288221-26696922-7930-44F3-A29E-1181AAD0ABD4

P2093

Q28288221-2DB2ACAE-AEBD-4125-9C4D-34A85BAD6F84

Q28288221-494C2DBB-0C85-4171-A8E2-43464A670B21

Q28288221-587DC2CE-D9E9-4063-AB4A-B9320A48055D

Q28288221-872A78E6-76B6-431E-B648-4D5EED78D187

Q28288221-9F5283AC-1BCF-4D1B-9842-403F9929DF77

Q28288221-B7CE3018-0541-46BE-AF3D-0DB9719110CD

Q28288221-C9ECBBD1-ABD7-4E68-81DB-359E52046ED0

Q28288221-E24E9D2F-FC82-4673-B533-9C9C4B6112A0

Q28288221-E788C337-0E7B-4CA4-837C-1B4A9CC6E888

Q28288221-F6F9E2EB-6F9F-4375-964D-A09DDBB37373

P304

Q28288221-07C68B1E-C464-4594-8DD1-4B1574071708

P31

Q28288221-40793D70-6DFB-4EDF-969B-2B58D1C2785F

P3181

Q28288221-36A39BC8-B157-466A-884A-0B4A625AEA27

P407

Q28288221-BECF5E57-4155-4817-B33D-DD8CEE620678

P433

Q28288221-7B943CFD-AA31-43CB-927C-17C45428AA85

P478

Q28288221-9FA3E7AB-3E1C-498F-BD59-DF8F86409920

P577

Q28288221-45EEB746-211D-4D54-BFB6-593D47948FA2

P698

Q28288221-45D55C55-8946-4A1F-97D4-1DC38A4A8B93

P3181

P1433

Journal of Pharmacology and Experimental Therapeutics

P1476

Neurochemical and behavioral e ...... stamine H3-receptor antagonist

@en

P2093

Elz S

http://www.w3.org/2001/XMLSchema#string

Ganellin CR

http://www.w3.org/2001/XMLSchema#string

Jouvet M

http://www.w3.org/2001/XMLSchema#string

Ligneau X

http://www.w3.org/2001/XMLSchema#string

Lin J

http://www.w3.org/2001/XMLSchema#string

Muir JL

http://www.w3.org/2001/XMLSchema#string

Schunack W

http://www.w3.org/2001/XMLSchema#string

Schwartz J

http://www.w3.org/2001/XMLSchema#string

Stark H

http://www.w3.org/2001/XMLSchema#string

Vanni-Mercier G

http://www.w3.org/2001/XMLSchema#string

P304

658-666

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

889190

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

287

http://www.w3.org/2001/XMLSchema#string

P577

1998-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9808693

http://www.w3.org/2001/XMLSchema#string